Tokyo Tape
Sign in
← MedPeer

Quarterly report · Q2

6095.TEDINET S100TEBI
Period2023-10-01 → 2024-03-31
Filed2024-05-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 48
MetricValuePeriodScopeSource row
Revenue¥7.9bn2023-10-01 → 2024-03-31Cons.Net sales
Revenue¥14.5bn2022-10-01 → 2023-09-30Cons.Net sales (5-year summary)
Revenue¥7.1bn2022-10-01 → 2023-03-31Cons.Net sales
Operating income¥836m2023-10-01 → 2024-03-31Cons.Operating income
Operating income¥717m2022-10-01 → 2023-03-31Cons.Operating income
Ordinary income¥831m2023-10-01 → 2024-03-31Cons.Ordinary income
Ordinary income¥1.2bn2022-10-01 → 2023-09-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥735m2022-10-01 → 2023-03-31Cons.Ordinary income
Profit before tax¥550m2023-10-01 → 2024-03-31Cons.Income before income taxes
Profit before tax¥735m2022-10-01 → 2023-03-31Cons.Income before income taxes
Net income (owners)¥199m2023-10-01 → 2024-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥618m2022-10-01 → 2023-09-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥380m2022-10-01 → 2023-03-31Cons.Profit loss attributable to owners of parent
Net income¥213m2023-10-01 → 2024-03-31Cons.Profit loss
Net income¥391m2022-10-01 → 2023-03-31Cons.Profit loss
Total assets¥14.9bnat 2024-03-31Cons.Assets
Total assets¥15.2bnat 2023-09-30Cons.Assets
Total assets¥14.5bnat 2023-03-31Cons.Total assets (5-year summary)
Total liabilities¥6.2bnat 2024-03-31Cons.Liabilities
Total liabilities¥6.6bnat 2023-09-30Cons.Liabilities
Net assets / equity¥8.7bnat 2024-03-31Cons.Net assets
Net assets / equity¥8.6bnat 2023-09-30Cons.Net assets
Net assets / equity¥8.6bnat 2023-03-31Cons.Net assets (5-year summary)
Cash and deposits¥5.8bnat 2024-03-31Cons.Cash and deposits
Cash and deposits¥5.4bnat 2023-09-30Cons.Cash and deposits
Cash & equivalents¥5.8bnat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥5.4bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥5.7bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥6.1bnat 2022-09-30dCons.Cash and cash equivalents
Operating cash flow¥807m2023-10-01 → 2024-03-31Cons.Net cash provided by used in operating activities
Operating cash flow¥600m2022-10-01 → 2023-09-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥122m2022-10-01 → 2023-03-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥47m2023-10-01 → 2024-03-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥5.0bn2022-10-01 → 2023-09-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥4.8bn2022-10-01 → 2023-03-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥378m2023-10-01 → 2024-03-31Cons.Net cash provided by used in financing activities
Financing cash flow¥3.7bn2022-10-01 → 2023-09-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥4.2bn2022-10-01 → 2023-03-31Cons.Net cash provided by used in financing activities
EPS (basic)¥9.182023-10-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-4.162024-01-01 → 2024-03-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥28.332022-10-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥17.422022-10-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥5.032023-01-01 → 2023-03-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥27.992022-10-01 → 2023-09-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥17.052022-10-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
Equity ratio56.5%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio54.7%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio57.6%at 2023-03-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 37
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-10-01 → 2024-03-31−¥434,000
Reconciling Itemsreconcilingrevenue intersegment2023-10-01 → 2024-03-31−¥434,000
Reconciling Itemsreconcilingsegment profit2023-10-01 → 2024-03-31−¥685m
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentrevenue2023-10-01 → 2024-03-31¥6.4bn
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentrevenue external2023-10-01 → 2024-03-31¥6.4bn
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentrevenue intersegment2023-10-01 → 2024-03-31¥15,000
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentsegment profit2023-10-01 → 2024-03-31¥1.5bn
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentrevenue2023-10-01 → 2024-03-31¥234m
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentrevenue external2023-10-01 → 2024-03-31¥234m
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentsegment profit2023-10-01 → 2024-03-31−¥131m
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentrevenue2023-10-01 → 2024-03-31¥1.2bn
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentrevenue external2023-10-01 → 2024-03-31¥1.2bn
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentrevenue intersegment2023-10-01 → 2024-03-31¥419,000
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentsegment profit2023-10-01 → 2024-03-31¥153m
—segment totalrevenue2023-10-01 → 2024-03-31¥7.9bn
—segment totalrevenue external2023-10-01 → 2024-03-31¥7.9bn
—segment totalrevenue intersegment2023-10-01 → 2024-03-31¥434,000
—segment totalsegment profit2023-10-01 → 2024-03-31¥1.5bn
Reconciling Itemsreconcilingrevenue2022-10-01 → 2023-03-31−¥5m
Reconciling Itemsreconcilingrevenue intersegment2022-10-01 → 2023-03-31−¥5m
Reconciling Itemsreconcilingsegment profit2022-10-01 → 2023-03-31−¥657m
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentrevenue2022-10-01 → 2023-03-31¥5.7bn
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentrevenue external2022-10-01 → 2023-03-31¥5.7bn
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentrevenue intersegment2022-10-01 → 2023-03-31¥2m
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentsegment profit2022-10-01 → 2023-03-31¥1.3bn
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentrevenue2022-10-01 → 2023-03-31¥243m
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentrevenue external2022-10-01 → 2023-03-31¥240m
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentrevenue intersegment2022-10-01 → 2023-03-31¥3m
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentsegment profit2022-10-01 → 2023-03-31−¥40m
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentrevenue2022-10-01 → 2023-03-31¥1.2bn
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentrevenue external2022-10-01 → 2023-03-31¥1.2bn
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentrevenue intersegment2022-10-01 → 2023-03-31¥300,000
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentsegment profit2022-10-01 → 2023-03-31¥94m
—segment totalrevenue2022-10-01 → 2023-03-31¥7.1bn
—segment totalrevenue external2022-10-01 → 2023-03-31¥7.1bn
—segment totalrevenue intersegment2022-10-01 → 2023-03-31¥5m
—segment totalsegment profit2022-10-01 → 2023-03-31¥1.4bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 519
ItemContextValueUnit
Number of shares heldCurrentQuarterInstant_No1MajorShareholdersMember5315490
Shareholding ratioCurrentQuarterInstant_No1MajorShareholdersMember0.2447
Number of shares heldCurrentQuarterInstant_No2MajorShareholdersMember1668400
Shareholding ratioCurrentQuarterInstant_No2MajorShareholdersMember0.0768
Number of shares heldCurrentQuarterInstant_No3MajorShareholdersMember1250000
Shareholding ratioCurrentQuarterInstant_No3MajorShareholdersMember0.0576
Number of shares heldCurrentQuarterInstant_No4MajorShareholdersMember900000
Shareholding ratioCurrentQuarterInstant_No4MajorShareholdersMember0.0414
Number of shares heldCurrentQuarterInstant_No5MajorShareholdersMember551200
Shareholding ratioCurrentQuarterInstant_No5MajorShareholdersMember0.0254
Number of shares heldCurrentQuarterInstant_No6MajorShareholdersMember524000
Shareholding ratioCurrentQuarterInstant_No6MajorShareholdersMember0.0241
Number of shares heldCurrentQuarterInstant_No7MajorShareholdersMember300800
Shareholding ratioCurrentQuarterInstant_No7MajorShareholdersMember0.0138
Number of shares heldCurrentQuarterInstant_No8MajorShareholdersMember262493
Shareholding ratioCurrentQuarterInstant_No8MajorShareholdersMember0.0121
Number of shares heldCurrentQuarterInstant_No9MajorShareholdersMember218000
Shareholding ratioCurrentQuarterInstant_No9MajorShareholdersMember0.0100
Number of shares heldCurrentQuarterInstant_No10MajorShareholdersMember217942
Shareholding ratioCurrentQuarterInstant_No10MajorShareholdersMember0.0100
Number of shares heldCurrentQuarterInstant11208325
Shareholding ratioCurrentQuarterInstant0.5160
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember－
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember－
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember－
Number of voting rights issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember－
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsTreasurySharesEtcMember266300
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember21689800
Number of voting rights issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember216898
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember30310
Number of shares issued shares voting rightsCurrentQuarterInstant21986410
Number of voting rights issued shares voting rightsCurrentQuarterInstant216898
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row1Member266300
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row1Member－
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member266300
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row1Member0.0121
Number of shares held in own name treasury shares etcCurrentQuarterInstant266300
Number of shares held in others names treasury shares etcCurrentQuarterInstant－
Total number of shares held treasury shares etcCurrentQuarterInstant266300
Shareholding ratio treasury shares etcCurrentQuarterInstant0.0121
Cash and depositsPrior1YearInstant5393167000JPY
Cash and depositsCurrentQuarterInstant5774053000JPY
Notes and accounts receivable trade and contract assetsPrior1YearInstant3429791000JPY
Notes and accounts receivable trade and contract assetsCurrentQuarterInstant3411988000JPY
Work in processPrior1YearInstant20377000JPY
Work in processCurrentQuarterInstant22176000JPY
Other caPrior1YearInstant340257000JPY
Other caCurrentQuarterInstant292462000JPY
Current assetsPrior1YearInstant9183595000JPY
Current assetsCurrentQuarterInstant9500680000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-09-30pass
balance sheet identityconsolidated 2024-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net income attributable to parentconsolidated 2022-10-01/2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2023-10-01/2024-03-31pass
statement vs summary · operating cash flowconsolidated 2022-10-01/2023-03-31pass
statement vs summary · operating cash flowconsolidated 2023-10-01/2024-03-31pass
statement vs summary · revenueconsolidated 2022-10-01/2023-03-31pass
statement vs summary · revenueconsolidated 2023-10-01/2024-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass